Eczema Trial, Recruiting (NCT06837454)

Eczema Trial, Recruiting NCT06837454 Sponsor: Sanofi Condition: Eczema

Printed from Voxsanity (voxsanity.com.au) — NCT06837454 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Eczema

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have signed (or are willing to sign) a consent form agreeing to take part in the study.
You have moderate to severe atopic dermatitis (eczema), as assessed by the study doctor, AND either: your symptoms are poorly controlled (based on a standard questionnaire score), you are using large amounts of steroid creams, steroid creams are not suitable for you, OR you are already receiving a treatment that works throughout the whole body (not just on the skin).
You are able to understand and fill in questionnaires related to the study.

Who may not be able to join:

You have a health condition, such as a very short life expectancy, serious memory or thinking problems, or substance misuse, that the study doctor believes could prevent you from fully taking part.
You are currently taking a body-wide (systemic) treatment, but only for a condition other than atopic dermatitis.
You are currently taking part in another clinical trial that involves a treatment or intervention.
You are under legal guardianship, court protection, or have had your freedom restricted by an official administrative or legal decision.

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 800-633-1610

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06837454

Sponsor: Sanofi

Phase: Not Applicable

Status: Recruiting

Condition: Eczema

Trial contact: 800-633-1610

More information: https://clinicaltrials.gov/study/NCT06837454

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have signed (or are willing to sign) a consent form agreeing to take part in the study.
You have moderate to severe atopic dermatitis (eczema), as assessed by the study doctor, AND either: your symptoms are poorly controlled (based on a standard questionnaire score), you are using large amounts of steroid creams, steroid creams are not suitable for you, OR you are already receiving a treatment that works throughout the whole body (not just on the skin).
You are able to understand and fill in questionnaires related to the study.

Who may not be able to join:

You have a health condition, such as a very short life expectancy, serious memory or thinking problems, or substance misuse, that the study doctor believes could prevent you from fully taking part.
You are currently taking a body-wide (systemic) treatment, but only for a condition other than atopic dermatitis.
You are currently taking part in another clinical trial that involves a treatment or intervention.
You are under legal guardianship, court protection, or have had your freedom restricted by an official administrative or legal decision.

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Sanofi

Registry

ClinicalTrials.gov

Start date

4 February 2025

Est. completion

13 May 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Previous and Current Treatments for Atopic Dermatitis (AD); Atopic Comorbidities: Previous and Current Therapeutic Management; Change from Baseline in Drug Survival for Systemic Treatments for AD by Name and Dose; Compliance for AD Treatments

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov